Correlation between tissue PD-L1, TMB, and blood PD-L1, MSI biomarkers in patients with advanced-stage non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Nandimandalam, Sujitha
Sharma, Nitika
机构：
[1] East Carolina Univ, Greenville, NC 27858 USA
[2] East Carolina Univ, Vidant Canc Care, Greenville, NC 27858 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21564
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Plasma cell-free RNA PD-L1 or Tissue PD-L1 Protein Expression and Immunotherapy Outcomes in Advanced Non-Small Cell Lung Cancer
    Walker, Paul R.
    Jayananda, Sriraksha
    Pasli, Melisa
    Muzaffarl, Mahvish
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E17 - E17
  • [22] PD-L1 Expression and its Correlation with Tumor TNM Stage in Patients with Non-Small Cell Lung Cancer
    Jang, T.
    Kim, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S532 - S532
  • [23] PD-L1-Gene Expression by nCounter Correlates with PD-L1 Protein Expression in Advanced Non-Small Cell Lung Cancer (NSCLC)
    Cabrera, C.
    Aguado, C.
    Teixido, C.
    Pare, L.
    Castellvi, J.
    Lopez, L.
    Marin, E.
    Bernal, X.
    Martinez, D.
    Gimenez-Capitan, A.
    Vinolas, N.
    Yeste, Z.
    Baixeras, N.
    Roman, R.
    Molina-Vila, M.
    Reguart, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S927 - S927
  • [24] Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer
    Gong, Bo
    Kiyotani, Kazuma
    Sakata, Seiji
    Nagano, Seiji
    Kumehara, Shun
    Baba, Satoko
    Besse, Benjamin
    Yanagitani, Noriko
    Friboulet, Luc
    Nishio, Makoto
    Takeuchi, Kengo
    Kawamoto, Hiroshi
    Fujita, Naoya
    Katayama, Ryohei
    JOURNAL OF EXPERIMENTAL MEDICINE, 2019, 216 (04): : 982 - 1000
  • [25] Predictive factors of response to PD-(L)1 inhibitors in patients with advanced non-small cell lung (NSCLC) and high PD-L1 expression
    Barba Joaquin, A.
    Piedra, A.
    Mosquera, J.
    Riudavets, M.
    Gomez-Randulfe, M. I.
    Garcia Campelo, M. R.
    Sullivan, I. G.
    Serra, J.
    Aguado, M.
    Majem Tarruella, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S768 - S769
  • [26] Spatial heterogeneity of PD-L1 expression and the risk for misclassification of PD-L1 immunohistochemistry in non-small cell lung cancer
    Dori, Shani Ben
    Aizic, Asaf
    Sabo, Edmond
    Hershkovitz, Dov
    LUNG CANCER, 2020, 147 : 91 - 98
  • [27] PD-1 and PD-L1 inhibitor toxicities in non-small cell lung cancer
    Shankar, Bairavi
    Naidoo, Jarushka
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S4034 - S4037
  • [28] Targeting the PD-1/PD-L1 axis in non-small cell lung cancer
    Kumar, Rajiv
    Collins, Dearbhaile
    Dolly, Saoirse
    McDonald, Fiona
    O'Brien, Mary E. R.
    Yap, Timothy A.
    CURRENT PROBLEMS IN CANCER, 2017, 41 (02) : 111 - 124
  • [29] Research progression of PD-1/PD-L1 in non-small cell lung cancer
    Xing Liu
    Xiaodong Xie
    Oncology and Translational Medicine, 2017, 3 (03) : 111 - 115
  • [30] The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs
    Tang, Yanna
    Fang, Wenfeng
    Zhang, Yaxiong
    Hong, Shaodong
    Kang, Shiyang
    Yan, Yue
    Chen, Nan
    Zhan, Jianhua
    He, Xiaobo
    Qin, Tao
    Li, Ge
    Tang, Wenyi
    Peng, Peijian
    Zhang, Li
    ONCOTARGET, 2015, 6 (16) : 14209 - 14219
12345